Understanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer
The positron emission tomography (PET) tracer 18F-fluciclovine has seen increasing use to localize disease in men with biochemical recurrence of prostate cancer, i.e., elevated prostate-specific antigen (PSA) levels post-treatment. 18F-Fluciclovine PET/computed tomography (CT) imaging reports now pl...
Saved in:
| Main Authors: | Benjamin H. Lowentritt, Michael S. Kipper |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Prostate Cancer |
| Online Access: | http://dx.doi.org/10.1155/2020/1929565 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
by: Cato C. Loeff, et al.
Published: (2024-11-01) -
Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer
by: Ivar S Jensen, et al.
Published: (2020-01-01) -
Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer
by: Marco M. E. Vogel, et al.
Published: (2025-01-01) -
PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
by: Nicole Handa, et al.
Published: (2025-05-01) -
18F-FDG PET/CT Imaging of Boari Flap Mimicking Urothelial Cancer Recurrence
by: Sharon E. Fishberg, et al.
Published: (2022-06-01)